Stacy Sherman

Director Program Management at ReCode Therapeutics

Stacy Sherman has a wealth of experience in the field of research and project management. Stacy began their career in 2008 as an intern at SGX Pharmaceuticals. In 2009, they joined Eli Lilly and Company as a Research Technician. In 2010, they moved to Pfizer as an Associate Scientist and was later promoted to Senior Associate Scientist. In 2015, Stacy joined BioMarin Pharmaceutical Inc. as a Scientist I and was subsequently promoted to Senior Research Associate and Senior Research Associate II. In 2020, Stacy joined Nutcracker Therapeutics as a Senior Manager, Project Management, Project Manager, and Scientist/Project Manager. In 2022, Stacy moved to Astellas Gene Therapies as a Senior Project Manager and to ReCode Therapeutics as an Associate Director of Early Research Program Management.

Stacy Sherman obtained a B.S. in Biological Sciences from UC Santa Barbara between 2003 and 2007. Stacy also holds a Project Management Professional (PMP) certification from the Project Management Institute.

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


ReCode Therapeutics

1 followers

ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases.


Industries

Employees

51-200

Links